Facet-Joint Injection Market Report 2026

Facet-Joint Injection Market Overview

• Facet-Joint Injection market size has reached to $2.97 billion in 2025 • Expected to grow to $4.1 billion in 2030 at a compound annual growth rate (CAGR) of 6.6% • Growth Driver: Rising Prevalence Of Spinal Conditions Fueling The Growth Of The Market Due To Increasing Demand For Effective Pain Management Solutions • Market Trend: Aurora Spine Secures FDA Clearance For Innovative AERO Facet Fusion System To Enhance Spinal Treatment Outcomes • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Facet-Joint Injection Market?

A facet joint injection is a minimally invasive procedure used to diagnose or treat pain originating from the facet joints, which are small joints between each pair of vertebrae in the spine. The injection typically contains a combination of a local anesthetic (to numb the area) and a corticosteroid (to reduce inflammation). A facet joint injection is commonly used to relieve chronic neck, back, or thoracic pain caused by arthritis or spinal degeneration. The main product types of the facet-joint injection include corticosteroids, local anesthetics, hyaluronic acid, and others. Corticosteroids are a class of steroid hormones used medically to reduce inflammation and suppress the immune system. The various applications involved are cervical facet joints, thoracic facet joints, lumbar facet joints, and facet joint injections, and they are used by several end-users, such as hospitals, ambulatory surgical centers, specialty clinics, and others.

What Is The Facet-Joint Injection Market Growth Forecast?

The facet-joint injection market size is expected to see strong growth in the next few years. It will grow to $4.1 billion in 2030 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to aging population, minimally invasive preference, chronic pain prevalence, ambulatory care expansion, imaging-guided procedures. Major trends in the forecast period include rising demand for minimally invasive pain procedures, increased use in chronic back pain management, growth of outpatient pain clinics, adoption of image-guided injection techniques, expansion of ambulatory surgical centers.

Global Facet-Joint Injection Market Segmentation

1) By Product Type: Corticosteroids, Local Anesthetics, Hyaluronic Acid, Other Product Types 2) By Application: Cervical Facet Joints, Thoracic Facet Joints, Lumbar Facet Joints 3) By End-User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Other End-Users Subsegments: 1) By Corticosteroids: Triamcinolone Acetonide, Methylprednisolone Acetate, Dexamethasone Sodium Phosphate, Betamethasone 2) By Local Anesthetics: Lidocaine, Bupivacaine, Ropivacaine, Prilocaine 3) By Hyaluronic Acid: High Molecular Weight Hyaluronic Acid, Low Molecular Weight Hyaluronic Acid, Cross-Linked Hyaluronic Acid, Non-Cross-Linked Hyaluronic Acid 4) By Other Product Types: Platelet-Rich Plasma, Biological Agents, Combination Formulations

What Are The Drivers Of The Facet-Joint Injection Market?

The rising prevalence of spinal diseases and chronic back pain is expected to propel the growth of the facet-joint injection market going forward. Spinal diseases and chronic back pain refer to long-term conditions affecting the spine, such as disc degeneration, arthritis, or nerve compression, that cause persistent discomfort, limited mobility, and reduced quality of life. The rising prevalence of spinal diseases and chronic back pain is due to sedentary lifestyles and poor posture habits, leading individuals to seek effective, low-disruption treatments that relieve persistent discomfort and restore functional movement. Facet-joint injection helps spinal diseases and chronic back pain by reducing pain and inflammation in the spine, providing relief for people suffering from the growing problem of spinal diseases and chronic back pain. For instance, in May 2023, according to Spinal Cord Inc., a US-based non-profit resource center, in 2023, around 18,000 new spinal cord injury (SCI) cases are reported annually in the United States, with an estimated 302,000 individuals currently living with spinal cord injuries nationwide. Therefore, the rising prevalence of spinal diseases and chronic back pain is driving the growth of the facet-joint injection industry. The growing demand for minimally invasive procedures is expected to propel the growth of the facet-joint injection market going forward. Minimally invasive procedures refer to medical interventions that are performed through small incisions or without the need for large surgical cuts. Minimally invasive procedures are increasing due to the growing patient preference for faster recovery times and reduced post-operative pain. Facet-joint injection enhances minimally invasive procedures by providing targeted pain relief and diagnostic accuracy without the need for extensive surgical intervention. For instance, in 2023, the American Society of Plastic Surgeons, a US-based specialty organization, indicated that the total number of minimally invasive cosmetic procedures rose from 23.7 million in 2022 to 25.4 million in 2023. Therefore, the growing demand for minimally invasive procedures is driving the growth of the facet-joint injection industry.

Key Players In The Global Facet-Joint Injection Market

Major companies operating in the facet-joint injection market are Abbott Laboratories, B. Braun Melsungen AG, BD (Becton Dickinson and Company), Cook Medical, Teleflex Incorporated, Merit Medical Systems Inc., Halyard Health, ICU Medical Inc., Pajunk GmbH Medizintechnologie, Avanos Medical Inc., Vygon SA, Cardinal Health Inc., Terumo Corporation, Nipro Corporation, Septodont Holding, Fresenius Kabi AG, Hikma Pharmaceuticals PLC, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Zydus Lifesciences Ltd., Amneal Pharmaceuticals LLC, Lupin Limited, Piramal Pharma Limited, Intas Pharmaceuticals Ltd., Gland Pharma Limited, Amphastar Pharmaceuticals Inc., Fresenius Medical Care, Baxter International Inc., McKesson Corporation

Global Facet-Joint Injection Market Trends and Insights

Major companies operating in the facet-joint injection market are focusing on developing innovative products, such as facet fusion systems, to offer longer-lasting relief and improve treatment outcomes. Facet fusion systems refer to medical devices designed to stabilize and fuse the facet joints of the spine by promoting bone growth between adjacent vertebrae. For instance, in March 2025, Aurora Spine Corporation, a US-based medical device company, announced that the AEROTM Facet Fusion System, its newest product, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). The system integrates titanium plasma spray coating to improve osseointegration and fusion potential. It supports multiple implant sizes to accommodate varied patient anatomies and offers radiolucent instrumentation to enhance intraoperative visibility. These features collectively aim to improve procedural efficiency and long-term outcomes in treating chronic back pain caused by facet joint disorders.

Regional Insights

North America was the largest region in the facet-joint injection market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Facet-Joint Injection Market?

The facet-joint injection market consists of revenues earned by entities through medication management, rehabilitation and psychological counseling, and interventional procedures. The market value includes the value of related goods sold by the service provider or included within the service offering. The facet-joint injection market also includes of sales of injection kits, imaging guidance systems, patient monitoring devices, and pain-relieving medications. Values in this market are ‘factory gate’ values, meaning the value of goods sold by the manufacturers or creators, whether to other companies (like distributors, clinics, and hospitals) or directly to end users. The value of goods in this market also includes related services provided by the creators, such as training or support for the use of injection products.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Facet-Joint Injection Market Report 2026?

The facet-joint injection market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the facet-joint injection industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.